KADMON

kadmon-logo

Kadmon Corporation, a biopharmaceutical company, offers products and services for the treatment and management of hepatitis C. Its products include Ribasphere RibaPak (ribavirin, USP) tablets, which help to reduce pill burden while providing patients with treatment that is biologically equivalent to other ribavirin medications; INFERGEN (interferon alfacon-1) to treat chronic hepatitis C in patients 18 years of age or older with compensated liver disease; Ribasphere (ribavirin, USP) tablets and ... capsules, which are antiviral medications for use in combination with other drugs for the treatment of chronic hepatitis C; and KD020, a reversible tyrosine kinase inhibitor that targets EGFR, HER2, VEGFR 2/3, and Src in autosomal dominant polycystic kidney disease (PKD). The company also provides various services and programs to support patients, prescribers, and pharmacies, including patient assistance programs to provide free medication to patients with limited or no insurance coverage; temporary shipments for patients on current or recent therapy; and nurse support services. In addition, it develops medicines in oncology, infectious diseases, immunology, and neurodegenerative diseases. The company was formerly known as Kadmon Holdings. Kadmon Corporation was incorporated in 2009 and is based in New York, New York with operations in Warrendale, Pennsylvania; and Boston, Massachusetts.

#SimilarOrganizations #People #Financial #Website #More

KADMON

Social Links:

Industry:
Biopharma Biotechnology Therapeutics

Founded:
2009-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.kadmon.com

Total Employee:
251+

Status:
Active

Contact:
2126832105

Email Addresses:
[email protected]

Total Funding:
629.47 M USD

Technology used in webpage:
LetsEncrypt Font Awesome Domain Not Resolving IPv6 Google Maps Google Maps API Apple Mobile Web App Capable GoDaddy Java EE Akamai Hosted


Similar Organizations

adamis-pharmaceuticals-logo

Adamis Pharmaceuticals

Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.

chiasma-logo

Chiasma

Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

innovent-biologics-logo

Innovent Biologics

Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.


Current Advisors List

harlan-w-waksal_image

Harlan W. Waksal Member of the Board of Directors @ Kadmon
Board_member
2013-12-01

Current Employees Featured

not_available_image

Michael J. Howerton
Michael J. Howerton Chief Operating and Financial Officer and Executive Vice President @ Kadmon
Chief Operating and Financial Officer and Executive Vice President

not_available_image

John L. Ryan
John L. Ryan Chief Medical officer and Executive Vice President @ Kadmon
Chief Medical officer and Executive Vice President

greg-moss_image

Greg Moss
Greg Moss Vice President, Office of General Counsel @ Kadmon
Vice President, Office of General Counsel
2012-01-01

not_available_image

Steven N. Gordon
Steven N. Gordon Chief Administrative @ Kadmon
Chief Administrative

harlan-w-waksal_image

Harlan W. Waksal
Harlan W. Waksal President & Chief Executive Officer @ Kadmon
President & Chief Executive Officer
2014-08-01

Founder


samuel-d-waksal_image

Samuel D. Waksal

Stock Details


Company's stock symbol is NYSE:KDMN

Investors List

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Post-IPO Equity - Kadmon

vivo-capital_image

Vivo Capital

Vivo Capital investment in Post-IPO Equity - Kadmon

acuta-capital-partners_image

Acuta Capital Partners

Acuta Capital Partners investment in Post-IPO Equity - Kadmon

Official Site Inspections

http://www.kadmon.com

Unable to get host informations!!!

Loading ...

More informations about "Kadmon"

Online Taiko & Fue Lessons - kaDON

KaDON is the world's best place to learn taiko and fue online. We feature expert instructors, comprehensive video lessons, and the best taiko and shinobue resources you can find. …See details»

Kadmon Corporation, LLC - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Kadmon Corporation, LLC of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»

Kadmon, a Sanofi Company | LinkedIn

Kadmon, a Sanofi Company, is a biopharmaceutical company that discovers, develops and markets transformative therapies for unmet medical needs. Our team has a proven track …See details»

Kadmon Company Profile | Management and Employees List

Kadmon Profile and History. Kadmon Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics within autoimmune and fibrotic, …See details»

Kadmon Corporation, LLC - New York City, USA - bionity.com

Kadmon Corporation, LLC is a global company built on a 21st-century paradigm for the translation of innovative science into treatment. The company currently offers products and services for …See details»

Kadmon Company Profile - Office Locations, Competitors ... - Craft

Kadmon $8.29 m in annual revenue in FY 2020. See insights on Kadmon including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Kadmon Holdings, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Kadmon Holdings, Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»

TCA Marketplace - Taiko Community Alliance

Email kaDON - [email protected]. Marco Lienhard | TAIKOZA* We offer professional-grade well-tuned Flutes (Shinobue and Shakuhachi). We also have student-level flutes (plastic and …See details»

Kadmon - Org Chart, Teams, Culture & Jobs - The Org

View Kadmon's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

Kadmon - Company Profile - Tracxn

Sep 6, 2024 Kadmon - Vertically integrated biopharmaceutical company targeting Autoimmune and Fibrotic Diseases, Oncology, Monogenic Diseases and Metabolic Diseases. Acquired by …See details»

Kadmon - VentureRadar

Website: http://www.kadmon.com/ Kadmon is a clinical-stage biopharmaceutical company that discovers, develops and delivers transformative therapies for unmet medical ...See details»

Sanofi completes acquisition of Kadmon - Yahoo Finance

Nov 9, 2021 Sanofi completes acquisition of Kadmon Paris – November 9, 2021 - Sanofi announced today the completion of its acquisition of Kadmon Holdings, Inc. The acquisition …See details»

Kadmon Holdings, Inc. - AnnualReports.com

Kadmon is a biopharmaceutical company developing innovative products for significant unmet medical needs. Their product pipeline is focused on inflammatory and fibrotic diseases as well …See details»

Kadmon - Crunchbase Company Profile & Funding

Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C. View contacts for Kadmon to access new leads and …See details»

Sanofi completes acquisition of Kadmon - Healthcare Global

Paris – November 9, 2021 – Sanofi announced today the completion of its acquisition of Kadmon Holdings, Inc. The acquisition further strengthens growth and expansion for the General …See details»

Kadmon - Funding, Financials, Valuation & Investors - Crunchbase

Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C.See details»

Sanofi completes acquisition of Kadmon

Nov 9, 2021 Sanofi completes acquisition of Kadmon. Paris – November 9, 2021 - Sanofi announced today the completion of its acquisition of Kadmon Holdings, Inc.The acquisition …See details»

Kadmon - Products, Competitors, Financials, Employees, …

Kadmon offers products and services for the treatment and management of liver diseases and is creating medicines in areas of serious disease, including oncology, immunology, and …See details»

linkstock.net © 2022. All rights reserved